GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hi-Clearance Inc (ROCO:1788) » Definitions » Cyclically Adjusted Price-to-FCF

Hi-Clearance (ROCO:1788) Cyclically Adjusted Price-to-FCF : 31.10 (As of Jun. 09, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Hi-Clearance Cyclically Adjusted Price-to-FCF?

As of today (2024-06-09), Hi-Clearance's current share price is NT$144.00. Hi-Clearance's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was NT$4.63. Hi-Clearance's Cyclically Adjusted Price-to-FCF for today is 31.10.

The historical rank and industry rank for Hi-Clearance's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

ROCO:1788' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 26.04   Med: 32.69   Max: 49.78
Current: 30.66

During the past years, Hi-Clearance's highest Cyclically Adjusted Price-to-FCF was 49.78. The lowest was 26.04. And the median was 32.69.

ROCO:1788's Cyclically Adjusted Price-to-FCF is ranked better than
60.76% of 237 companies
in the Medical Devices & Instruments industry
Industry Median: 42.66 vs ROCO:1788: 30.66

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Hi-Clearance's adjusted free cash flow per share data for the three months ended in Mar. 2024 was NT$-1.392. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is NT$4.63 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Hi-Clearance Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Hi-Clearance's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hi-Clearance Cyclically Adjusted Price-to-FCF Chart

Hi-Clearance Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 31.81 36.97 43.73 26.59

Hi-Clearance Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.59 28.30 28.16 27.78 30.23

Competitive Comparison of Hi-Clearance's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Hi-Clearance's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hi-Clearance's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hi-Clearance's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Hi-Clearance's Cyclically Adjusted Price-to-FCF falls into.



Hi-Clearance Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Hi-Clearance's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=144.00/4.63
=31.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hi-Clearance's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Hi-Clearance's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1.392/131.7762*131.7762
=-1.392

Current CPI (Mar. 2024) = 131.7762.

Hi-Clearance Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -1.190 99.695 -1.573
201406 -3.500 100.560 -4.587
201409 3.152 100.428 4.136
201412 1.576 99.070 2.096
201503 -1.568 99.621 -2.074
201506 -1.729 100.684 -2.263
201509 4.340 100.392 5.697
201512 0.050 99.792 0.066
201603 1.972 100.470 2.586
201606 0.811 101.688 1.051
201609 3.175 101.861 4.107
201612 3.008 101.863 3.891
201703 0.436 102.862 0.559
201706 0.959 103.349 1.223
201709 0.789 104.136 0.998
201712 1.526 104.011 1.933
201803 1.354 105.290 1.695
201806 1.548 106.317 1.919
201809 -4.987 106.507 -6.170
201812 3.374 105.998 4.195
201903 1.252 107.251 1.538
201906 -0.156 108.070 -0.190
201909 1.946 108.329 2.367
201912 2.548 108.420 3.097
202003 0.961 108.902 1.163
202006 3.155 108.767 3.822
202009 1.801 109.815 2.161
202012 -1.344 109.897 -1.612
202103 -1.363 111.754 -1.607
202106 0.356 114.631 0.409
202109 -2.104 115.734 -2.396
202112 6.445 117.630 7.220
202203 -1.270 121.301 -1.380
202206 3.658 125.017 3.856
202209 -0.111 125.227 -0.117
202212 5.065 125.222 5.330
202303 -0.612 127.348 -0.633
202306 2.643 128.729 2.706
202309 2.446 129.860 2.482
202403 -1.392 131.776 -1.392

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hi-Clearance  (ROCO:1788) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Hi-Clearance Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Hi-Clearance's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Hi-Clearance (ROCO:1788) Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Chongzhong Road, Lane 609, 8th Floor, Section 5, Taipei, TWN
Hi-Clearance Inc manufactures medical devices. It is engaged in the biochemical reagents and western medicine trading business. Its products are dialyzer, dialysis machine, RO machine, cardiac, radiation and implant surgery devices, dental consumables implant material & equipments & blood glucose monitor & nutrition products.

Hi-Clearance (ROCO:1788) Headlines

No Headlines